TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Celsion Lead
Play
INVESTING

Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug

PRESS RELEASES

Celsion Corporation Provides Clinical Update On Phase I/II OVATION 2 Study With GEN-1 In Advanced Ovarian Cancer Including Encouraging Interim Resection Scores

PRESS RELEASES

Celsion Receives $2 Million Allocation Through The New Jersey Technology Business Tax Certificate Transfer (NOL) Program

Celsion Lead
INVESTING

Celsion Surges as FDA Fast-Tracks Ovarian-Cancer Drug

PRESS RELEASES

Celsion Corporation Announces Formation Of Vaccine Advisory Board

PRESS RELEASES

Celsion Corporation Issues Letter To Stockholders

PRESS RELEASES

Celsion Corporation Files Provisional U.S. Patent Application For A Broad Range Of Next Generation DNA Vaccines

PRESS RELEASES

CELSION CORPORATION ANNOUNCES CLOSING OF $35 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES

PRESS RELEASES

CELSION CORPORATION ANNOUNCES $35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

PRESS RELEASES

DEADLINE TODAY: The Schall Law Firm Announces It Is Investigating Claims Against Celsion Corporation And Encourages Investors With Losses To Contact The Firm

PRESS RELEASES

DEADLINE TOMORROW: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Celsion Corporation And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

PRESS RELEASES

ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Celsion Corporation Investors Of Important December 29 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - CLSN

PRESS RELEASES

ROSEN, A LEADING LAW FIRM, Reminds Celsion Corporation Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - CLSN

PRESS RELEASES

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Celsion Corporation Of Class Action Lawsuit And Upcoming Deadline - CLSN

PRESS RELEASES

CLSN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Celsion Corporation Shareholders With Losses Exceeding $100K Of Class Action And Lead Plaintiff Deadline: December 28, 2020

PRESS RELEASES

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Reminds Celsion Corporation Investors Of Important Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - CLSN

PRESS RELEASES

Celsion Corporation To Hold Third Quarter 2020 Financial Results And Business Update Conference Call On Monday, November 16, 2020

PRESS RELEASES

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Celsion Corporation Investors Of Important December 29 Deadline In Securities Class Action; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - CLSN

PRESS RELEASES

ROSEN, TRUSTED AND LEADING INVESTOR COUNSEL, Announces Filing Of Securities Class Action Lawsuit Against Celsion Corporation; Encourages Investors With Losses In Excess Of $100K To Contact The Firm - CLSN

PRESS RELEASES

CLSN Investor Alert - Bronstein, Gewirtz & Grossman, LLC Notifies Celsion Corporation Shareholders With Losses Exceeding $100K Of Class Action And Lead Plaintiff Deadline: December 28, 2020

PRESS RELEASES

ROSEN, A TOP RANKED LAW FIRM, Announces Filing Of Securities Class Action Lawsuit Against Celsion Corporation - CLSN

PRESS RELEASES

CELSION ALERT: Bragar Eagel & Squire, P.C. Announces That A Class Action Lawsuit Has Been Filed Against Celsion Corporation And Encourages Investors To Contact The Firm

PRESS RELEASES

Pomerantz Law Firm Announces The Filing Of A Class Action Against Celsion Corporation Certain Officers - CLSN

PRESS RELEASES

Celsion Corporation Issues Letter To Stockholders

PRESS RELEASES

Celsion Announces Common Stock Purchase Agreement With Lincoln Park Capital And Provides Updates On OVATION 2 Study